Status:
NOT_YET_RECRUITING
Leveraging Chatbot to Improve PrEP in the Southern United States
Lead Sponsor:
Yale University
Collaborating Sponsors:
Gilead Sciences
Conditions:
HIV Prevention
PrEP Awareness
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to develop a chatbot intervention to promote PrEP awareness and uptake among Black men who have sex with men (MSM) in the Southern United States.
Detailed Description
In the United States (US), the epicenter of the HIV epidemic is in the South. The HIV-related death rate in the US South is high, but engagement with quality HIV prevention services and care is low. A...
Eligibility Criteria
Inclusion
- Being cisgender Black male
- Being aged ≥ 18 years
- Having Internet access
- Speaking English
- Self-reporting condomless sex with another man in the past 6 months
- HIV negative or untested.
Exclusion
- Having lived in the US South less than 3 months
- Having received antiretroviral therapy (ART) treatment.
Key Trial Info
Start Date :
October 28 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
145 Patients enrolled
Trial Details
Trial ID
NCT05968755
Start Date
October 28 2025
End Date
February 1 2026
Last Update
July 28 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Care 4 U Community Health Center
Miami, Florida, United States, 33127
2
Community Care Resources of FL (CCRSFL)
Pembroke Pines, Florida, United States, 33027
3
NAESM, Inc
Atlanta, Georgia, United States, 30318
4
RAO Community Health
Charlotte, North Carolina, United States, 28202